It is essential to assess the severity of multiple sclerosis (MS) in order to choose appropriate therapeutic measures, but this cannot be reliably done using existing methods. A MedUni Vienna study now shows for the first time that the retina can be used as a prognostic marker. Analyses revealed that retinal layer thinning as a […]
Gene therapy research repairs nerve transport systems damaged by glaucoma and dementia: Results of the pre-clinical study, led by Professor Keith Martin from the Centre for Eye Research Australia and University of Melbourne and Dr Tasneem Khatib from the University of Cambridge, are published today in Science Advances. Researchers say the findings in experiments on mice show […]
Targets for avoidable sight loss ‘not being met’, 30-year study finds: A new global study has found no significant reduction in the number of people with treatable sight loss since 2010. Published in The Lancet Global Health, it examined population-based surveys of eye disease worldwide from 1980 and found public health services across the world are […]
Read More… from Targets for avoidable sight loss ‘not being met’, 30-year study finds
Gene therapy research regenerates optic nerve, bringing hope for future glaucoma treatment: Researchers have used gene therapy to regenerate damaged optic nerve fibres in a discovery that could help treat glaucoma, one of the world’s leading causes of blindness. The pre-clinical study, led by Professor Keith Martin from the Centre for Eye Research Australia and […]
Read More… from Glaucoma: gene therapy regenerates optic nerve
One million people in the UK are living with avoidable sight loss severe enough to have a significant impact on their daily lives – leaving them unable to do things such as drive. And worryingly, this number is forecast to rise by a third by 2030, if we don’t take action now. Eyesight declines as […]
Read More… from One million people living with avoidable sight loss